Fulminant myocarditis as an early presentation of SARS-CoV-2.
BMJ Case Rep
; 13(9)2020 Sep 14.
Article
in English
| MEDLINE | ID: covidwho-767817
ABSTRACT
Myocarditis is well known to be caused by viral infections such as Coxsackie virus group B, human herpes virus 6 and parvovirus B19. However, during the current emerging outbreak of SARS-CoV-2, there have been few case reports describing myocarditis as a possible presentation. In our case report we describe, early cardiac manifestations of SARS-CoV-2 in a UK District General Hospital. A 44-year-old Caucasian woman without any comorbidities presented with SARS-CoV-2 related fulminant myocarditis without initial respiratory symptoms. Patient underwent treatment with milrinone and methylprednisolone that showed reduction in myocardial inflammation and significantly improved myocardial contractility. This was then followed by a second phase of SARS-CoV-2 associated pneumonia and renal failure requiring ventilatory support and haemofiltration. Although, not described in the literature, we have found conjunctive use of milrinone and methylprednisolone effective in patient with SARS-CoV-2 fulminant myocarditis.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Coronavirus Infections
/
Myocarditis
Type of study:
Case report
/
Diagnostic study
Limits:
Adult
/
Female
/
Humans
Language:
English
Year:
2020
Document Type:
Article
Affiliation country:
Bcr-2020-237553
Similar
MEDLINE
...
LILACS
LIS